All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for INFECTIOUS DISEASES SOCIETY OF AMERICA · Medical association promoting public health and prevention of infectious diseases

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 17, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Lobbyists on this filing 2

BLAKE THELANDER New on this filing

Previously held: Health Policy Advisor/Legislative Director, Rep. Mariannette Miller-Meeks (2023-2025), Staff Assistant/Legislative Assistant/Senior Legislative Assistant, Rep. Jefferson Van Drew (2020-2023), Intern, Rep. Ralph Norman (2019-2019)
KELSEY GRISWOLD-BERGER New on this filing

Previously held: Sr Policy Advisor, Sen McCormick (2025); LA, Sen Burr (2021-23); Leg Dir, Rep C Smith (2018-21); Leg Dir, Rep Pittenger (2018); Leg Dir, Rep Blum (2017-18); LA, Rep Perry (2015-17); LA (2014-15), LC/Press Asst (2011-14), SA (2011), Rep Reed

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
HR 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
HR 4445
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Legislation related to anti-microbial resistance generally

Budget/Appropriations

H.R. 1 (One Big Beautiful Bill Act), regarding funding for infectious diseases programs generally H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill

Medicare/Medicaid

Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.